These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 22016712)
1. Does α-amino-β-methylaminopropionic acid (BMAA) play a role in neurodegeneration? Chiu AS; Gehringer MM; Welch JH; Neilan BA Int J Environ Res Public Health; 2011 Sep; 8(9):3728-46. PubMed ID: 22016712 [TBL] [Abstract][Full Text] [Related]
2. A critical review of the postulated role of the non-essential amino acid, β-N-methylamino-L-alanine, in neurodegenerative disease in humans. Chernoff N; Hill DJ; Diggs DL; Faison BD; Francis BM; Lang JR; Larue MM; Le TT; Loftin KA; Lugo JN; Schmid JE; Winnik WM J Toxicol Environ Health B Crit Rev; 2017; 20(4):1-47. PubMed ID: 28598725 [TBL] [Abstract][Full Text] [Related]
3. Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases. Bradley WG; Mash DC Amyotroph Lateral Scler; 2009; 10 Suppl 2():7-20. PubMed ID: 19929726 [TBL] [Abstract][Full Text] [Related]
4. Biomagnification of cyanobacterial neurotoxins and neurodegenerative disease among the Chamorro people of Guam. Cox PA; Banack SA; Murch SJ Proc Natl Acad Sci U S A; 2003 Nov; 100(23):13380-3. PubMed ID: 14612559 [TBL] [Abstract][Full Text] [Related]
5. Is there a role for naturally occurring cyanobacterial toxins in neurodegeneration? The beta-N-methylamino-L-alanine (BMAA) paradigm. Papapetropoulos S Neurochem Int; 2007 Jun; 50(7-8):998-1003. PubMed ID: 17296249 [TBL] [Abstract][Full Text] [Related]
6. A mechanism for slow release of biomagnified cyanobacterial neurotoxins and neurodegenerative disease in Guam. Murch SJ; Cox PA; Banack SA Proc Natl Acad Sci U S A; 2004 Aug; 101(33):12228-31. PubMed ID: 15295100 [TBL] [Abstract][Full Text] [Related]
12. Presence of ß-N-methylamino-L-alanine in cyanobacteria and aquatic organisms from waters of Northern Poland; BMAA toxicity studies. Błaszczyk A; Siedlecka-Kroplewska K; Woźniak M; Mazur-Marzec H Toxicon; 2021 Apr; 194():90-97. PubMed ID: 33610631 [TBL] [Abstract][Full Text] [Related]
13. Is Exposure to BMAA a Risk Factor for Neurodegenerative Diseases? A Response to a Critical Review of the BMAA Hypothesis. Ra D; Sa B; Sl B; Js M; Sj M; DA D; Ew S; O K; Eb B; Ad C; Vx T; Gg G; Pa C; Dc M; Wg B Neurotox Res; 2021 Feb; 39(1):81-106. PubMed ID: 33547590 [TBL] [Abstract][Full Text] [Related]
17. The Potential Role of BMAA in Neurodegeneration. Caller T; Henegan P; Stommel E Neurotox Res; 2018 Jan; 33(1):222-226. PubMed ID: 28612294 [TBL] [Abstract][Full Text] [Related]
18. Cyanobacteria, neurotoxins and water resources: are there implications for human neurodegenerative disease? Metcalf JS; Codd GA Amyotroph Lateral Scler; 2009; 10 Suppl 2():74-8. PubMed ID: 19929737 [TBL] [Abstract][Full Text] [Related]
19. A Single Neonatal Exposure to BMAA in a Rat Model Produces Neuropathology Consistent with Neurodegenerative Diseases. Scott LL; Downing TG Toxins (Basel); 2017 Dec; 10(1):. PubMed ID: 29286334 [TBL] [Abstract][Full Text] [Related]
20. Cyanobacterial Neurotoxin Beta-Methyl-Amino-l-Alanine Affects Dopaminergic Neurons in Optic Ganglia and Brain of Brooke-Jones M; Gáliková M; Dircksen H Toxins (Basel); 2018 Dec; 10(12):. PubMed ID: 30544796 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]